NeuroSense schedules FDA meeting for ALS drug trial By Investing.com
CAMBRIDGE, Mass. - NeuroSense Therapeutics Ltd. (NASDAQ: NRSN), a biotech agency specializing in neurodegenerative illness therapies, has secured a Kind ...
Friday, May 8, 2026
Tag: drug
Medicare drug plans are getting better next year — but some will also cost more
When Pam McClure realized she’d save almost $4,000 on her pharmaceuticals subsequent 12 months, she stated, “it sounded too good ...
RECOMMENDED
Iran labels UAE ‘Israeli proxy,’ warns of military action in Gulf region
## Market Snapshot Iran’s labeling of the UAE as an “Israeli proxy” has heightened tensions within the Gulf area. Markets...
Copyright © 2024 PWC.